Zebin Yang
Impact in
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Nanoplatforms for cancer theranostics 14
-
- Advanced Nanomaterials in Catalysis 6
- Co-authors
- Hangrong Chen (9 shared papers)Yu Luo (4 shared papers)Kanyi Pu (2 shared papers)Jiaguo Huang (2 shared papers)Shasha He (2 shared papers)Jing Li (2 shared papers)Dong Cui (2 shared papers)Yan Zhang (2 shared papers)
In The Last Decade
Zebin Yang
26 papers receiving 956 citations
Zebin Yang's Hit Papers
Peers
Comparison fields: 5 of 87
- Biomedical Engineering 760
- Biomaterials 197
- Materials Chemistry 364
- Immunology 146
- Biochemistry 48
Countries citing papers authored by Zebin Yang
This map shows the geographic impact of Zebin Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zebin Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zebin Yang more than expected).
Fields of papers citing papers by Zebin Yang
This network shows the impact of papers produced by Zebin Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zebin Yang. The network helps show where Zebin Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Zebin Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Organic Semiconducting Pro‐nanostimulants for Near‐Infrared Photoactivatable Cancer Immunotherapy Hit paper breakdown → | 2019 | 285 |
| 2 | 2020 | 92 | |
| 3 | 2021 | 87 | |
| 4 | 2021 | 77 | |
| 5 | 2022 | 63 | |
| 6 | 2019 | 56 | |
| 7 | 2022 | 51 | |
| 8 | 2019 | 50 | |
| 9 | 2019 | 40 | |
| 10 | 2022 | 34 | |
| 11 | 2022 | 31 | |
| 12 | 2021 | 31 | |
| 13 | 2019 | 15 | |
| 14 | 2023 | 12 | |
| 15 | 2023 | 6 | |
| 16 | 2022 | 5 | |
| 17 | 2020 | 5 | |
| 18 | 2023 | 4 | |
| 19 | 2023 | 4 | |
| 20 | 2023 | 4 |
About Zebin Yang
Zebin Yang is a scholar working on Biomedical Engineering, Materials Chemistry, Immunology, Pulmonary and Respiratory Medicine and Biochemistry, having authored 28 papers that have together received 961 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (14 papers), Advanced Nanomaterials in Catalysis (6 papers), Sulfur Compounds in Biology (4 papers), Advanced Photocatalysis Techniques (4 papers), Immune cells in cancer (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Cancer, Stress, Anesthesia, and Immune Response (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). The work is most often cited by research in Biomedical Engineering (760 citations), Biomaterials (197 citations), Materials Chemistry (364 citations), Immunology (146 citations) and Biochemistry (48 citations). Zebin Yang has collaborated with scholars based in China, Germany and Singapore. Frequent co-authors include Hangrong Chen, Yu Luo, Kanyi Pu, Jiaguo Huang, Shasha He, Jing Li, Dong Cui, Yan Zhang, Kaicheng Liang and Huizhu Yu. Their work appears in journals such as Advanced Functional Materials, Nano Research, Frontiers in Oncology, Nano Today and International Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.